Novel protein ADTRP regulates TFPI expression and function in human endothelial cells in normal conditions and in response to androgen
Novel protein ADTRP regulates TFPI expression and function in human endothelial cells in normal conditions and in response to androgen
复制标题
DOI:
10.1182/blood-2011-05-355370
复制
发表时间:
2011-10-20
期刊:
影响因子:
20.3
通讯作者:
Lupu, Florea
中科院分区:
文献类型:
--
作者:
Lupu, Cristina;Zhu, Hua;Lupu, Florea
Thrombosis and cardiovascular disease (CVD) represent major causes of morbidity and mortality. Low androgen correlates with higher incidence of CVD/thrombosis. Tissue Factor Pathway Inhibitor (TFPI) is the major inhibitor of tissue factor-factor VIIa (TF-FVIIa)-dependent FXa generation. Because endothelial cell (EC) dysfunction leading to vascular disease correlates with low EC-associated TFPI, we sought to identify mechanisms that regulate the natural expression of TFPI. Data mining of NCBI's GEO microarrays revealed strong coexpression between TFPI and the uncharacterized protein encoded by C6ORF105, which is predicted to be multispan, palmitoylated and androgen-responsive. We demonstrate that this protein regulates both the native and androgen-enhanced TFPI expression and activity in cultured ECs, and we named it androgen-dependent TFPI-regulating protein (ADTRP). We confirm ADTRP expression and colocalization with TFPI and caveolin-1 in ECs. ADTRP-shRNA reduces, while over-expression of ADTRP enhances, TFPI mRNA and activity and the colocalization of TF-FVIIa-FXa-TFPI with caveolin-1. Imaging and Triton X-114-extraction confirm TFPI and ADTRP association with lipid rafts/caveolae. Dihydrotestosterone up-regulates TFPI and ADTRP expression, and increases FXa inhibition by TFPI in an ADTRP- and caveolin-1-dependent manner. We conclude that the ADTRP-dependent upregulation of TFPI expression and activity by androgen represents a novel mechanism of increasing the anticoagulant protection of the endothelium. (Blood. 2011;118(16):4463-4471)